KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Crescent Capital BDC (CCAP) Cash & Equivalents (2021 - 2025)

Crescent Capital BDC (CCAP) has disclosed Cash & Equivalents for 5 consecutive years, with $3.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash & Equivalents rose 181.23% year-over-year to $3.9 million, compared with a TTM value of $3.9 million through Sep 2025, up 181.23%, and an annual FY2024 reading of $10.1 million, up 30.21% over the prior year.
  • Cash & Equivalents was $3.9 million for Q3 2025 at Crescent Capital BDC, up from $1.4 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $12.7 million in Q3 2022 and bottomed at $1.4 million in Q3 2024.
  • Average Cash & Equivalents over 5 years is $6.3 million, with a median of $6.6 million recorded in 2021.
  • The sharpest move saw Cash & Equivalents plummeted 76.73% in 2024, then soared 181.23% in 2025.
  • Year by year, Cash & Equivalents stood at $10.1 million in 2021, then rose by 26.55% to $12.7 million in 2022, then plummeted by 38.94% to $7.8 million in 2023, then skyrocketed by 30.21% to $10.1 million in 2024, then tumbled by 61.24% to $3.9 million in 2025.
  • Business Quant data shows Cash & Equivalents for CCAP at $3.9 million in Q3 2025, $1.4 million in Q2 2025, and $4.2 million in Q1 2025.